Prediction of Outcome of Non Invasive Ventilation COPD Patients by Assessment of Diaphragmatic Performance
Can Transthoracic Ultrasound Assessment of the Diaphragmatic Performance Predict the Outcome of Non Invasive Ventilation in Critically Ill COPD Patients With Acute Exacerbation
1 other identifier
observational
155
0 countries
N/A
Brief Summary
Transthoracic ultrasonographic assessment of the diaphragmatic performance as a predictor for the outcome of NIV in critically ill COPD patients with acute exacerbation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2027
November 22, 2023
November 1, 2023
3 years
November 7, 2023
November 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
ultrasonographic assessement of COPD patients
To assess the diaphragmatic performance by transthoracic ultrasound in critically ill COPD patients with acute exacerbation
Baseline
Secondary Outcomes (1)
Time saving
Baseline
Interventions
The following parameters will be assessed by TUS: Diaphragmatic copulae position and mobility (inspiratory time, excursion, diaphragmatic thickening fraction TF , excursion time E-T index )
Eligibility Criteria
COPD patients admitted to respiratory intensive care unit with acute exacerbation
You may qualify if:
- One Hundred fifty five critically ill COPD patients admitted to respiratory intensive care unit
- Diagnosis of COPD and COPD exacerbation is fulfilled according to GOLD 2022 criteria
- Age\>40years
You may not qualify if:
- Age ˂ 40 years.
- Refusal to participate in the study.
- Patients with morbid obesity (BMI\>40).
- Absolute indication for intubation like coma ,hemodynamic instability, or life threatening arrhythmia.
- Contraindication to NIV like untreated pneumothorax, pneumothorax with air leak, widespread facial burn or trauma, tracheotomy, or active upper gastrointestinal bleeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, Yang IA. Acute exacerbation of COPD. Respirology. 2016 Oct;21(7):1152-65. doi: 10.1111/resp.12780. Epub 2016 Mar 30.
PMID: 27028990BACKGROUNDRittayamai N, Chuaychoo B, Tscheikuna J, Dres M, Goligher EC, Brochard L. Ultrasound Evaluation of Diaphragm Force Reserve in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2020 Oct;17(10):1222-1230. doi: 10.1513/AnnalsATS.202002-129OC.
PMID: 32614240BACKGROUNDSchulz A, Erbuth A, Boyko M, Vonderbank S, Gurleyen H, Gibis N, Bastian A. Comparison of Ultrasound Measurements for Diaphragmatic Mobility, Diaphragmatic Thickness, and Diaphragm Thickening Fraction with Each Other and with Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2022 Sep 12;17:2217-2227. doi: 10.2147/COPD.S375956. eCollection 2022.
PMID: 36118281BACKGROUND
Related Links
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 7, 2023
First Posted
November 22, 2023
Study Start
November 15, 2023
Primary Completion (Estimated)
November 15, 2026
Study Completion (Estimated)
December 15, 2027
Last Updated
November 22, 2023
Record last verified: 2023-11